Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia

Chest

Volumn 142, Issue 2, 2012, Pages 513-516

  Kaya, Hatice ^a   Gümüş, Seyfettin ^a   Uçar, Ergun ^a   Aydogan, Mehmet ^a   Muşabak, Ugur ^a   Tozkoparan, Ergun ^a   Bilgiç, Hayati ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; IMMUNOGLOBULIN E; OMALIZUMAB; PREDNISONE;

ADULT; AMENORRHEA; ARTICLE; ASTHMA; B LYMPHOCYTE; CASE REPORT; COUGHING; DEPRESSION; EOSINOPHILIA; FEMALE; FLOW CYTOMETRY; HUMAN; LOEFFLER PNEUMONIA; LUNG INFILTRATE; NIGHT SWEAT; PRICK TEST; PRIORITY JOURNAL; RELAPSE; REMISSION; THORAX RADIOGRAPHY; WEIGHT REDUCTION; WHEEZING;

EID: 84864819156     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1881     Document Type: Article

References (10)

1. Marchand E, Reynaud-Gaubert M, Lauque D, Durieu J, Tonnel AB, Cordier JF. Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines"Pulmonaires (GERM"O"P). Medicine (Baltimore). 1998;77(5):299-312.
2. Mankad VS, Burks AW. Omalizumab: other indications and unanswered questions. Clin Rev Allergy Immunol. 2005;29(1):17-30.
3. Wechsler ME, Wong DA, Miller MK, Lawrence-Miyasaki L. Churg-strauss syndrome in patients treated with omalizumab. Chest. 2009;136(2):507-518.
4. Cazzola M, Mura M, Segreti A, Mattei MA, Rogliani P. Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome? Allergy. 2009;64(9):1389-1390.
5. Pabst S, Tiyerili V, Grohé C. Apparent response to anti-IgE therapy in two patients with refractory "forme fruste" of Churg-Strauss syndrome. Thorax. 2008;63(8):747-748.
6. Noga O, Hanf G, Brachmann I, et al. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma. J Allergy Clin Immunol. 2006;117(6):1493-1499.
7. Acharya M, Borland G, Edkins AL, et al. CD23/FcεRII: molecular multi-tasking. Clin Exp Immunol. 2010;162(1):12-23.
8. Ford JW, Sturgill JL, Conrad DH. 129/SvJ mice have mutated CD23 and hyper IgE. Cell Immunol. 2009;254(2):124-134.
9. Rothenberg ME, Klion AD, Roufosse FE, et al;Mepolizumab HES Study Group. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med. 2008;358(12):1215-1228.
10. Kim S, Marigowda G, Oren E, Israel E, Wechsler ME. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. J Allergy Clin Immunol. 2010;125(6):1336-1343.